Literature DB >> 26980302

Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis.

Michelle M Angrish1, Jonathan Phillip Kaiser2, Charlene A McQueen1, Brian N Chorley3.   

Abstract

Hepatic steatosis is a condition were fat accumulates in the liver and it is associated with extra-hepatic diseases related to metabolic syndrome and systemic energy metabolism. If not reversed, steatosis can progress to steatohepatitis and irreversible stages of liver disease including fibrosis, cirrhosis, hepatocellular carcinoma, and death. From a public health standpoint, identifying chemical exposures that may be factors in steatosis etiology are important for preventing hepatotoxicity and liver disease progression. It is therefore important to identify the biological events that are key for steatosis pathology mediated by chemical exposure. In this review, we give a current overview of the complex biological cascades that can disrupt lipid homeostasis in hepatocytes in the context of 4 apical key events central to hepatic lipid retention: hepatic fatty acid (FA) uptake,de novoFA and lipid synthesis, FA oxidation, and lipid efflux. Our goal is to review these key cellular events and visually summarize them using a network for application in pathway-based toxicity testing. This effort provides a foundation to improve next-generation chemical screening efforts that may be used to prevent and ultimately reverse the growing incidence of fatty liver disease in our population. Published by Oxford University Press on behalf of the Society of Toxicology 2016. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  adverse outcome pathway; chemical risk assessment.; high-throughput screening assays; mechanistic toxicology; non-alcoholic fatty liver disease; steatosis

Mesh:

Substances:

Year:  2016        PMID: 26980302     DOI: 10.1093/toxsci/kfw018

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  19 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.

Authors:  Kaberi P Das; Carmen R Wood; Mimi T Lin; Anatoly A Starkov; Christopher Lau; Kendall B Wallace; J Christopher Corton; Barbara D Abbott
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

3.  Advancing the adverse outcome pathway framework-An international horizon scanning approach.

Authors:  Carlie A LaLone; Gerald T Ankley; Scott E Belanger; Michelle R Embry; Geoff Hodges; Dries Knapen; Sharon Munn; Edward J Perkins; Murray A Rudd; Daniel L Villeneuve; Maurice Whelan; Catherine Willett; Xiaowei Zhang; Markus Hecker
Journal:  Environ Toxicol Chem       Date:  2017-06       Impact factor: 3.742

4.  Adverse outcome pathway networks I: Development and applications.

Authors:  Dries Knapen; Michelle M Angrish; Marie C Fortin; Ioanna Katsiadaki; Marc Leonard; Luigi Margiotta-Casaluci; Sharon Munn; Jason M O'Brien; Nathan Pollesch; L Cody Smith; Xiaowei Zhang; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2018-05-07       Impact factor: 3.742

Review 5.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

6.  Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.

Authors:  Rance Nault; Kelly A Fader; Todd A Lydic; Timothy R Zacharewski
Journal:  Chem Res Toxicol       Date:  2017-03-20       Impact factor: 3.739

Review 7.  Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.

Authors:  Roland Buesen; Brian N Chorley; Beatriz da Silva Lima; George Daston; Lize Deferme; Timothy Ebbels; Timothy W Gant; Amber Goetz; John Greally; Laura Gribaldo; Jörg Hackermüller; Bruno Hubesch; Danyel Jennen; Kamin Johnson; Jun Kanno; Hans-Martin Kauffmann; Madeleine Laffont; Patrick McMullen; Richard Meehan; Mark Pemberton; Stefania Perdichizzi; Aldert H Piersma; Ursula G Sauer; Kerstin Schmidt; Hervé Seitz; Kayo Sumida; Knut E Tollefsen; Weida Tong; Tewes Tralau; Ben van Ravenzwaay; Ralf J M Weber; Andrew Worth; Carole Yauk; Alan Poole
Journal:  Regul Toxicol Pharmacol       Date:  2017-09-25       Impact factor: 3.271

8.  Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.

Authors:  Michelle M Angrish; Charlene A McQueen; Elaine Cohen-Hubal; Maribel Bruno; Yue Ge; Brian N Chorley
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

9.  Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Heather B Clair; Barbara J Clark; Brian P Ceresa; Russell A Prough; Matthew C Cave
Journal:  Xenobiotica       Date:  2017-06-21       Impact factor: 1.908

10.  Hepatic signalling disruption by pollutant Polychlorinated biphenyls in steatohepatitis.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Hongxue Shi; Jian Jin; Daniel Wilkey; Michael Merchant; Corey Watson; Russell A Prough; Matthew C Cave
Journal:  Cell Signal       Date:  2018-10-06       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.